Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Divestments (2022 - 2025)

Historic Divestments for Bio-Techne (TECH) over the last 8 years, with Q3 2025 value amounting to $1.4 million.

  • Bio-Techne's Divestments fell 370.63% to $1.4 million in Q3 2025 from the same period last year, while for Dec 2025 it was $2.6 million, marking a year-over-year increase of 8538.85%. This contributed to the annual value of $17.8 million for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Bio-Techne's Divestments stood at $1.4 million, which was down 370.63% from $1.2 million recorded in Q1 2025.
  • Bio-Techne's 5-year Divestments high stood at $17.8 million for Q3 2022, and its period low was $1.2 million during Q1 2025.
  • For the 4-year period, Bio-Techne's Divestments averaged around $4.8 million, with its median value being $1.4 million (2024).
  • Its Divestments has fluctuated over the past 5 years, first tumbled by 8794.32% in 2023, then plummeted by 370.63% in 2025.
  • Quarter analysis of 4 years shows Bio-Techne's Divestments stood at $17.8 million in 2022, then plummeted by 87.94% to $2.1 million in 2023, then crashed by 34.71% to $1.4 million in 2024, then fell by 3.71% to $1.4 million in 2025.
  • Its Divestments stands at $1.4 million for Q3 2025, versus $1.2 million for Q1 2025 and $1.4 million for Q3 2024.